Concepedia

Infliximab–Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies

Haggai Bar‐Yoseph, Sigal Pressman, Alexandra Blatt, Shiran Gerassy Vainberg, Naama Maimon, Elina Starosvetsky, Bella Ungar, Shomron Ben‐Horin, Shai S. Shen-Orr, Yehuda Chowers

Gastroenterology · 2019 · 39 citations · 32 references

DOI

Concepts

References

32

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

, , +12

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

, , +14

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

Filip Baert, Maja Noman, Séverine Vermeire et al. · New England Journal of Medicine · 2003 · 2K citations · Full text

, , +17

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen et al. · The American Journal of Gastroenterology · 2012 · 796 citations

, , +13

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease

Stephen B. Hanauer, Carrie Wagner, Mohan Bala et al. · Clinical Gastroenterology and Hepatology · 2004 · 608 citations · Full text

, , +16